Artificial Intelligence In Diagnostics Market Size, Share & Trends Analysis Report By Component (Software, Hardware, Services), By Diagnosis (Cardiology, Oncology, Pathology, Radiology, Chest And Lung, Neurology), By Region, And Segment Forecasts, 2025 -

Artificial Intelligence In Diagnostics Market Growth & Trends

The global artificial intelligence in diagnostics market size is expected to reach USD 5.44 billion in 2030 and is expected to grow at a CAGR of 22.46% during the forecast period, according to a new report by Grand View Research, Inc. The growing demand for integrating AI-enabled algorithms in diagnostics to provide precise and accurate diagnosis at the earliest, which enhances clinical and operational outcomes, is driving the growth of this market. The rapidly growing cases of acute & chronic disorders across the globe are driving the demand for AI-based solutions since most of these ailments could be either prevented or delayed if diagnosed early and given appropriate treatments. The shortage of healthcare personnel is also supporting the product demand.

The emergence of startups, increasing funding opportunities, and growing public-private partnerships are also boosting market growth. Furthermore, medical technology is witnessing significant transitions & transformations and is rapidly adopting advanced AI-powered solutions to provide precise diagnosis, which enables care providers to design adequate treatment plans. Radiology and pathology are widely implementing AI-based algorithms & solutions and have provided proven results. In radiology, these solutions use information collected from multiple modalities to create image datasets to run data analysis, which could be used by the radiologist in delivering an accurate and timely diagnosis. Similarly, in pathology, these solutions could be integrated to run data analysis and provide accurate results.

The growing burden of chronic conditions across the global population is also driving the demand for AI-based diagnostic solutions. The key participants in AI in diagnostics market are focusing on the development of new, innovative products and the expansion of their business offerings to gain a competitive edge over others. In addition, many startups specializing in the development of advanced AI-based technologies are receiving favorable support and funding opportunities. This will also have a positive impact on the overall market growth. For instance, in September 2018, IDx received funding of USD 33 million from Optum Ventures and 8VC and the company will use this funding for the development of innovative AI-based solutions.

Artificial Intelligence In Diagnostics Market Report Highlights

  • Technological advancements driven by the increasing demand for early and accurate disease detection, improving patient outcomes, further results in significant innovations.
  • Based on components, the software solutions segment dominated the market with a revenue share of 45.81% in 2024 and is expected to witness the fastest growth rate during the forecast period.
  • Neurology had a significant revenue share of 24.09% in 2024.
  • The oncology segment is expected to grow at the fastest CAGR during the forecast period.
  • North America artificial intelligence in diagnostics market dominated in 2024 with the largest share of 54.74%.
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Component
1.1.2. Diagnosis
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline.
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database.
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Component outlook
2.2.2. Diagnosis outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Artificial Intelligence In Diagnostics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.2.3. Market opportunity analysis
3.2.4. Market challenges analysis
3.3. Artificial Intelligence In Diagnostics Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
3.3.3. COVID-19 Impact
3.4. Case Study
Chapter 4. Artificial Intelligence In Diagnostics Market: Component Estimates & Trend Analysis
4.1. Component Market Share, 2024 & 2030
4.2. Segment Dashboard
4.3. Global Artificial Intelligence In Diagnostics Market by Component Outlook
4.4. Software
4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5. Hardware
4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.6. Services
4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Artificial Intelligence In Diagnostics Market: Diagnosis Estimates & Trend Analysis
5.1. Diagnosis Market Share, 2024 & 2030
5.2. Segment Dashboard
5.3. Global Artificial Intelligence In Diagnostics Market by Diagnosis Outlook
5.4. Cardiology
5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.5. Oncology
5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.6. Pathology
5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.7. Radiology
5.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.8. Chest and Lung
5.8.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.9. Neurology
5.9.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.10. Others
5.10.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Artificial Intelligence In Diagnostics Market: Regional Estimates & Trend Analysis, By Component, By Diagnosis
6.1. Regional Market Share Analysis, 2024 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.5. North America
6.5.1. U.S.
6.5.1.1. Key country dynamics
6.5.1.2. Regulatory framework
6.5.1.3. Competitive scenario
6.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
6.5.2. Canada
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework
6.5.2.3. Competitive scenario
6.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
6.5.3. Mexico
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework
6.5.3.3. Competitive scenario
6.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Europe
6.6.1. UK
6.6.1.1. Key country dynamics
6.6.1.2. Regulatory framework
6.6.1.3. Competitive scenario
6.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
6.6.2. Germany
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework
6.6.2.3. Competitive scenario
6.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
6.6.3. France
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework
6.6.3.3. Competitive scenario
6.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
6.6.4. Italy
6.6.4.1. Key country dynamics
6.6.4.2. Regulatory framework
6.6.4.3. Competitive scenario
6.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
6.6.5. Spain
6.6.5.1. Key country dynamics
6.6.5.2. Regulatory framework
6.6.5.3. Competitive scenario
6.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
6.6.6. Norway
6.6.6.1. Key country dynamics
6.6.6.2. Regulatory framework
6.6.6.3. Competitive scenario
6.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
6.6.7. Sweden
6.6.7.1. Key country dynamics
6.6.7.2. Regulatory framework
6.6.7.3. Competitive scenario
6.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
6.6.8. Denmark
6.6.8.1. Key country dynamics
6.6.8.2. Regulatory framework
6.6.8.3. Competitive scenario
6.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
6.7. Asia Pacific
6.7.1. Japan
6.7.1.1. Key country dynamics
6.7.1.2. Regulatory framework
6.7.1.3. Competitive scenario
6.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
6.7.2. China
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework
6.7.2.3. Competitive scenario
6.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
6.7.3. India
6.7.3.1. Key country dynamics
6.7.3.2. Regulatory framework
6.7.3.3. Competitive scenario
6.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
6.7.4. Australia
6.7.4.1. Key country dynamics
6.7.4.2. Regulatory framework
6.7.4.3. Competitive scenario
6.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
6.7.5. South Korea
6.7.5.1. Key country dynamics
6.7.5.2. Regulatory framework
6.7.5.3. Competitive scenario
6.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
6.7.6. Thailand
6.7.6.1. Key country dynamics
6.7.6.2. Regulatory framework
6.7.6.3. Competitive scenario
6.7.6.4. Singapore market estimates and forecasts 2018 to 2030 (USD Million)
6.8. Latin America
6.8.1. Brazil
6.8.1.1. Key country dynamics
6.8.1.2. Regulatory framework
6.8.1.3. Competitive scenario
6.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
6.8.2. Argentina
6.8.2.1. Key country dynamics
6.8.2.2. Regulatory framework
6.8.2.3. Competitive scenario
6.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
6.9. MEA
6.9.1. South Africa
6.9.1.1. Key country dynamics
6.9.1.2. Regulatory framework
6.9.1.3. Competitive scenario
6.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
6.9.2. Saudi Arabia
6.9.2.1. Key country dynamics
6.9.2.2. Regulatory framework
6.9.2.3. Competitive scenario
6.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
6.9.3. UAE
6.9.3.1. Key country dynamics
6.9.3.2. Regulatory framework
6.9.3.3. Competitive scenario
6.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
6.9.4. Kuwait
6.9.4.1. Key country dynamics
6.9.4.2. Regulatory framework
6.9.4.3. Competitive scenario
6.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Innovators
7.4. Vendor Landscape
7.4.1. Key company market share analysis, 2024
7.4.2. Siemens Healthineers
7.4.2.1. Company overview
7.4.2.2. Financial performance
7.4.2.3. Technology Type benchmarking
7.4.2.4. Strategic initiatives
7.4.3. Zebra Technologies Corp.
7.4.3.1. Company overview
7.4.3.2. Financial performance
7.4.3.3. Technology Type benchmarking
7.4.3.4. Strategic initiatives
7.4.4. Riverain Technologies
7.4.4.1. Company overview
7.4.4.2. Financial performance
7.4.4.3. Technology Type benchmarking
7.4.4.4. Strategic initiatives
7.4.5. Vuno, Inc.
7.4.5.1. Company overview
7.4.5.2. Financial performance
7.4.5.3. Technology Type benchmarking
7.4.5.4. Strategic initiatives
7.4.6. Aidoc
7.4.6.1. Company overview
7.4.6.2. Financial performance
7.4.6.3. Technology Type benchmarking
7.4.6.4. Strategic initiatives
7.4.7. NovaSignal Corporation (previously known as Neural Analytics, acquired by NeuraSignal, Inc.)
7.4.7.1. Company overview
7.4.7.2. Financial performance
7.4.7.3. Technology Type benchmarking
7.4.7.4. Strategic initiatives
7.4.8. Imagen
7.4.8.1. Company overview
7.4.8.2. Financial performance
7.4.8.3. Technology Type benchmarking
7.4.8.4. Strategic initiatives
7.4.9. Digital Diagnostics, Inc.
7.4.9.1. Company overview
7.4.9.2. Financial performance
7.4.9.3. Technology Type benchmarking
7.4.9.4. Strategic initiatives
7.4.10. GE Healthcare
7.4.10.1. Company overview
7.4.10.2. Financial performance
7.4.10.3. Technology Type benchmarking
7.4.10.4. Strategic initiatives
7.4.11. AliveCor Inc.
7.4.11.1. Company overview
7.4.11.2. Financial performance
7.4.11.3. Technology Type benchmarking
7.4.11.4. Strategic initiatives
7.4.12. F. Hoffmann-La Roche Ltd
7.4.12.1. Company overview
7.4.12.2. Financial performance
7.4.12.3. Technology Type benchmarking
7.4.12.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings